Ulcerative Colitis Treatment Market to Reach $12.79 Billion by 2033 | Biologics, Biosimilars & Small Molecules Rise
Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. AUSTIN, TX, UNITED STATES, October 28, 2025 /EINPresswire.com/ -- According to DataM …